Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 1463 entries
View as:

Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)

Phase: N/A Priority: Normal
NCT ID: NCT02642471 Org: User:
Start: 12/31/15 End: 12/31/24 Due: 12/31/25

Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT06854510 Org: User:
Start: 02/21/25 End: 02/28/30 Due: 02/28/31

Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01245959 Org: User:
Start: 01/31/11 End: 04/30/18 Due: 04/30/19

Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04400851 Org: User:
Start: 08/11/20 End: 12/10/21 Due: 12/10/22

Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03970694 Org: User:
Start: 05/11/19 End: 06/05/22 Due: 06/05/23

Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA

Phase: N/A Priority: Normal
NCT ID: NCT05334277 Org: User:
Start: 05/06/22 End: 02/29/28 Due: 02/28/29

Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT02093910 Org: User:
Start: 04/30/14 End: 04/30/18 Due: 04/30/19

Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04384627 Org: User:
Start: 12/01/19 End: 10/01/26 Due: 10/01/27

Lymphadenectomy in Early Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04710797 Org: User:
Start: 01/31/21 End: 12/31/28 Due: 12/31/29

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

Phase: N/A Priority: Normal
NCT ID: NCT05549466 Org: User:
Start: 10/08/22 End: 09/20/25 Due: 09/20/26

Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06268652 Org: User:
Start: 01/15/24 End: 01/15/28 Due: 01/15/29

Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.

Phase: N/A Priority: Normal
NCT ID: NCT05397769 Org: User:
Start: 06/08/22 End: 12/31/26 Due: 12/31/27

Biomarker for Peritoneal Ultrafiltration Failure

Phase: N/A Priority: Normal
NCT ID: NCT00728806 Org: User:
Start: 10/31/07 End: 12/31/11 Due: 12/31/12

Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01218594 Org: User:
Start: 05/31/09 End: 12/31/15 Due: 12/31/16

Impact of Body Mass Index and Lipid Metabolism on Anti-PD-1 Immunotherapy Outcomes in Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07012174 Org: User:
Start: 01/01/19 End: 04/30/25 Due: 04/30/26

Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501）

Phase: N/A Priority: Normal
NCT ID: NCT06924398 Org: User:
Start: 04/20/25 End: 12/31/25 Due: 12/31/26

Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT03800797 Org: User:
Start: 05/25/15 End: 12/10/15 Due: 12/10/16

Adolescents' Non-suicidal Behavior and Perception of Parents' Negative Emotional Expression and Family Communication

Phase: N/A Priority: Normal
NCT ID: NCT06290115 Org: User:
Start: 04/01/24 End: 12/31/24 Due: 12/31/25

Predictive Value of Postoperative Circulating Tumor DNA Monitoring for Colorectal Cancer Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT06143644 Org: User:
Start: 01/15/22 End: 06/30/27 Due: 06/30/28

Effects of Topical Anesthesia With Pressure Nebulized 2% Lidocaine During Awake Intubation

Phase: N/A Priority: Normal
NCT ID: NCT01185535 Org: User:
Start: 01/31/10 End: 12/31/10 Due: 12/31/11

Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05201859 Org: User:
Start: 03/29/22 End: 02/15/26 Due: 02/15/27

Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02610556 Org: User:
Start: 01/31/16 End: 01/31/22 Due: 01/31/23

Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)

Phase: N/A Priority: Normal
NCT ID: NCT06313190 Org: User:
Start: 04/05/24 End: 04/30/30 Due: 04/30/31

Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01669369 Org: User:
Start: 01/31/13 End: 12/31/23 Due: 12/31/24

A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03997539 Org: User:
Start: 08/15/19 End: 12/30/21 Due: 12/30/22